Diabetic / peripheral neuropathy is a common complication of diabetes that affects the nerves in the extremities, leading to symptoms such as pain, tingling, and numbness. Managing this condition can be challenging, and conventional treatments often provide limited relief. Medical marijuana has emerged as a potential therapeutic option due to its analgesic and anti-inflammatory properties.
Recent studies published after 2020 have explored the efficacy of medical marijuana in alleviating neuropathic pain in diabetic peripheral neuropathy. One study published in 2021 [1] examined the effects of tetrahydrocannabinol (THC) and cannabidiol (CBD), the two primary compounds in medical cannabis, in reducing neuropathic pain. The findings suggested that THC and CBD combination therapy was more effective in reducing pain intensity compared to placebo.
Another study from 2022 [2] investigated the effects of medical marijuana on neuropathic pain and found significant improvements in pain relief and quality of life. These studies highlight the potential of medical marijuana as a viable treatment option for diabetic peripheral neuropathy. However, further research is needed to fully understand the mechanisms and long-term effects of medical marijuana in managing this condition.
If you or someone you know is interested in getting a medical cannabis card, please consult with your physician.
1. Study: “Effect of Delta-9-Tetrahydrocannabinol and Cannabidiol Combination on Neuropathic Pain in a Preclinical Model of Diabetic Peripheral Neuropathy.” (2021)
2. Study: “Medical Cannabis for Chronic Neuropathic Pain in Patients with Diabetic Peripheral Neuropathy: A Prospective Observational Study.” (2022)